Skip to main content
. Author manuscript; available in PMC: 2020 Jun 1.
Published in final edited form as: J Card Fail. 2018 Jun 7;24(12):842–848. doi: 10.1016/j.cardfail.2018.05.007

Table 2.

Duration of hospitalization, Follow-Up and Crude All-Cause Mortality Rates in Patients With Heart Failure in the Trivandrum Heart Failure Registry

Variable Total (n = 1205) HFpEF (EF ≥ 45%; n = 311) HFrEF (EF <45%; n = 894) P Value
Duration of index hospitalization, median (IQR) 6 (4–9) 6 (4–9) 6 (4–9) .353
In-hospital mortality, n (%) 102 (8.5) 15 (4.8) 87 (9.7) .003
Cumulative 30-day mortality, n (%) 151 (12.5) 25 (8.0) 126 (14.1) .003
Cumulative 90-day mortality, n (%) 218 (18.1) 44 (14.2) 174 (19.5) .018
Cumulative 1-year mortality, n (%) 371 (30.8) 85 (27.3) 286 (32.0) .061
Cumulative 2-year mortality, n (%) 492 (40.8) 114 (36.7) 378 (42.3) .041
Cumulative 3-year mortality, n (%) 540 (44.8) 127 (40.8) 413 (46.2) .049

HFpEF, heart failure with preserved ejection fraction; HFrEF, heart failure with reduced ejection fraction; EF, ejection fraction; COPD, chronic obstructive pulmonary disease; CKD, chronic kidney disease; NYHA, New York Heart Association; ACE-I, angiotensin-converting enzyme inhibitor; ARB, angiotensin-receptor blocker.